Not just another kinase. new knowledge about myeloproliferative disease
Bjerrum, O.W.
Ugeskrift for Laeger 168(39): 3293
2006
ISSN/ISBN: 1603-6824 PMID: 17032590 Document Number: 603234
Document emailed within 1 workday
Related Documents
Frye, F.L.; Carney, J. 1972: Myeloproliferative disease in a turtle Journal of the American Veterinary Medical Association 161(6): 595-599Shafran, N.; Gewurtz, G.; Priel, I.E. 1992: Splenic hemorrhage masquerading as myeloproliferative disease Harefuah 122(4): 218-220
Görg, C.; Görg, K.; Pflüger, K.H.; Havemann, K. 1988: A primary skin tumor in myeloproliferative disease Der Internist 29(9): 645-648
Penka, M.; Kissová, J.; Buliková, A.; Zavrelová, J.; Ovesná, J.; Pavlík, T. 2011: Thrombohaemorrhagic syndrome in patients with a myeloproliferative disease with thrombocythemia Vnitrni Lekarstvi 57(3): 306-311
Verhoef, G.E.; Demuynck, H.; Zachee, P.; Boogaerts, M.A. 1994: Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two? Leukemia 8(4): 714-715
Aviram, M.; Carter, A.; Tatarsky, I.; Levy, Y.; Brook, J.G. 1985: Increased platelet aggregation following splenectomy in patients with myeloproliferative disease Israel Journal of Medical Sciences 21(5): 415-417
Simarro, M.; Calvo, J.; Vilà, J.M.; Places, L.; Padilla, O.; Alberola-Ila, J.; Vives, J.; Lozano, F. 1999: Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase Journal of Immunology 162(9): 5149-5155
Dulícek, P.; Voglová, J.; Malý, J. 2010: Surgical interventions in patients with myeloproliferative disease--prophylaxis and treatment of haemostatic disorders Vnitrni Lekarstvi 56(1): 61-66
Rendu, F.; Lebret, M.; Nurden, A.; Caen, J.P. 1979: Detection of an acquired platelet storage pool disease in three patients with a myeloproliferative disorder Thrombosis and Haemostasis 42(2): 794-796
László, I.án.; Gábor, V.; Zsolt, B.; László, T.; József, J.ór. 2009: Synchronous myeloproliferative and inflammatory disease of the nasal cavity and paranasal sinuses: an interesting differential diagnostic problem Rhinology 47(3): 323-326
Jennings, F.; Toffolo, S.; de Assis, M.R.; Natour, J. 2006: Brazil Patient Knowledge Questionnaire (PKQ) and evaluation of disease-specific knowledge in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 24(5): 521-528
Seed, T.M.; Meyers, S.M. 1993: Chronic radiation-induced alteration in hematopoietic repair during preclinical phases of aplastic anemia and myeloproliferative disease: assessing unscheduled DNA synthesis responses Cancer Research 53(19): 4518-4527
Gilbert, H.S. 1984: Myelofibrosis revisited: characterization and classification of myelofibrosis in the setting of myeloproliferative disease Progress in Clinical and Biological Research 154: 3-17
Lee, S.-H.; 임윤택 2015: Identification of Knowledge Driven Production Path through ICTs Industry as a Tool of Knowledge Sharing and Knowledge Management in Knowledge City Journal of The Korean Urban Management Association 28(2): 409-434
Presek, P.; Glossmann, H.; Eigenbrodt, E.; Schoner, W.; Rübsamen, H.; Friis, R.R.; Bauer, H. 1980: Similarities between a phosphoprotein (pp60src)-associated protein kinase of Rous sarcoma virus and a cyclic adenosine 3':5'-monophosphate-independent protein kinase that phosphorylates pyruvate kinase type M2 Cancer Research 40(5): 1733-1741
Sato, K.; Nagayama, H.; Tadokoro, K.; Juji, T.; Takahashi, T.A. 1999: Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-alpha-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells Journal of Immunology 162(7): 3865-3872
Mohri, M.; Shimokawa, H. 2003: Rho-kinase inhibitors for ischemic heart disease Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 5): 874-879
King, D.T.; Fu, P.C.; Wishon, G.M. 1978: Persistent creatine kinase MB isoenzyme without cardiac disease Archives of Pathology and Laboratory Medicine 102(9): 481-482
Fernhout, F.; Wielders, J.; Dijstelbloem, H.; Kraaijenhagen, R.; Prins, J. 2004: Increased serum activity of creatine kinase: usually not a sign of disease Nederlands Tijdschrift Voor Geneeskunde 148(7): 345-346
Cosentino, F. 2003: Statins in cardiovascular disease. Role of Rho/Rho kinase inhibition and of Akt activation Recenti Progressi in Medicina 94(10): 444-450